A part of MilliporeSigma

Small Molecule Pharmaceuticals

Request Information

High-Quality Products and Services for Small Molecules

Developing a new pharmaceutical drug is a complex and challenging process. As the leader in high-quality products and services for the chemical and pharmaceutical industries, we offer everything you need to optimize development and reduce time to market for your therapeutic small molecules.

And with our comprehensive EMPROVE® dossiers we provide detailed, usage-specific documentation for more than 400 pharma raw materials that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges to the release of your small molecules.
  • A continually updated portfolio for evolving markets and regulatory requirements
  • A wide range of customer-centric services
  • Tailor-made production quantities on a global scale
  • Expertise and state-of-the-art equipment backed by a complete matrix of production technologies capable of fulfilling more than 95% of all common chemical reactions
  • Full service throughout the entire development chain supporting you in chemical as well as regulatory aspects
  • cGMP-certified and FDA-inspected development and production sites

News Releases

Oct 06, 2016
MilliporeSigma Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea

MilliporeSigma today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.

20161006 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 05, 2016
MilliporeSigma’s Udit Batra Receives CPhI’s ‘CEO of the Year’ Award

MilliporeSigma today announced that CEO Udit Batra was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.

20161005 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 26, 2016
MilliporeSigma Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal

MilliporeSigma today launched the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.

20160926 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 08, 2016
MilliporeSigma Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines

MilliporeSigma today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically-defined, animal component-free manufacturing processes.

20160908 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
View All News
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!
Functional excipients to enhance bioavailability. Learn More

Functional Excipients
to enhance bioavailability.

Learn More
Sign up for our pharmail newsletter – more news, more service - Click here

pharmail Newsletter
More news, more service

Sign up now!


Nov 09
Filtration and Filling Seminar
Barcelona, Spain
Europe 20161109